Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
<h4>Introduction</h4>Currently available clinical assays to detect antiphospholipid antibodies (aPL) test for IgG and IgM antibodies to cardiolipin (aCL) and β2-glycoprotein I (aβ2GPI). It has been suggested that testing for IgA aPL and for antibodies to Domain I (DI), which carries the...
Main Authors: | Charis Pericleous, Isabel Ferreira, Orietta Borghi, Francesca Pregnolato, Thomas McDonnell, Acely Garza-Garcia, Paul Driscoll, Silvia Pierangeli, David Isenberg, Yiannis Ioannou, Ian Giles, Pier Luigi Meroni, Anisur Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0156407 |
Similar Items
-
IgA in IgA nephropathy
by: Layward, Lorna
Published: (1992) -
Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
by: Maria Gabriella Raimondo, et al.
Published: (2017-01-01) -
IgA glycosylation in IgA nephropathy
by: Allen, Alice
Published: (1995) -
Abnormal Aspects of IgA in IgA Nephropathy
by: Akash Nabil, et al.
Published: (2000-01-01) -
The role of filtered IgA in the progression of IgA nephropathy
by: Cheung, Chee Kay
Published: (2017)